Stock Events

Stock Events

Relmada Therapeutics (4E2.STU) Q2 2026 Earnings

12MayConfirmed

Q2 2026

-0.19

-0.18

-0.18

-0.17

Details

Expected EPS

-0.1706876766

Actual EPS

-0.18743780000000002

Surprise EPS

-0.02

Surprise Percent

+9.81%

Description

Relmada Therapeutics (4E2.STU) has reported earnings of -0.18743780000000002 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.